The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions.
about
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerAmerican Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix.Emerging Infections Program--State Health Department Perspective.Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012.Screening adolescents and young womenImpact of HPV immunization on the detection of cervical disease.Population-based surveillance for cervical cancer precursors in three central cancer registries, United States 2009.Maximizing the Impact of Human Papillomavirus Vaccination.Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States.Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: Associations with race, ethnicity, and poverty.Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region.American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical CancerAn ontology-driven approach to mobile data collection applications for the healthcare industry
P2860
Q24607403-12C84A1E-EC8C-4754-AFE3-A282CFA52E09Q26828840-CAD8617A-0591-419D-A5A5-2189D98467C6Q33745439-84FC1FCB-A5F4-4B89-B482-041A20529AE8Q35997425-23095C89-19CA-4F31-BC26-E3E94C082002Q35997434-31C00206-1BE8-4DF6-82ED-EA1EE4A2B3DAQ36903551-F91BCA99-177F-4409-86FF-778B784279BAQ38194249-EE5E9BEE-911F-4D1A-9AE6-A5B6748022AEQ38399679-82ACEFE4-1E77-4344-9A40-168D24483299Q40207559-05285D21-C2E1-4689-8B5A-B3787E58E7EEQ40812471-CA74C435-049C-4207-BA77-2320D3C214C8Q43893716-C965F82A-F34C-45F0-AD16-C4540E01CAE6Q47599014-3F1774CD-E04B-4005-815C-A70D77DD72CAQ57089342-E8EA0718-0AA7-48D6-8AB1-883AA587929DQ58402153-1DD11FEA-06C1-4D0C-9121-9E9D6B1F7AEE
P2860
The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
The HPV vaccine impact monitor ...... ical cancer precursor lesions.
@en
The HPV vaccine impact monitoring project
@nl
type
label
The HPV vaccine impact monitor ...... ical cancer precursor lesions.
@en
The HPV vaccine impact monitoring project
@nl
prefLabel
The HPV vaccine impact monitor ...... ical cancer precursor lesions.
@en
The HPV vaccine impact monitoring project
@nl
P2093
P2860
P1476
The HPV vaccine impact monitor ...... ical cancer precursor lesions.
@en
P2093
HPV-IMPACT Working Group
Heidi M Bauer
Karen C Bloch
Linda M Niccolai
Nancy M Bennett
Sean Schafer
Susan Hariri
Suzanne E Powell
P2860
P2888
P304
P356
10.1007/S10552-011-9877-6
P577
2011-11-23T00:00:00Z
P6179
1025458969